Concept explainers
Bacteriophage-Inspired Antibiotics Although bacteriophages have been infecting bacteria for billions of years, no mechanism, has evolved in bacteria to prevent the viruses from lysing the cell walls of their hosts. Now, scientists are targeting the same bacterial wall components that bacteriophages do. The goal is to develop antibiotics that bacteria will be less likely to develop resistance to.
FIGURE 20.22 shows the results of a study to test Epimerox, a new bacteriophage-inspired antibiotic, against Bacillus anthracis, the bacterial species that causes the disease anthrax.
FIGURE 20.22 Effect of Epimerox on the survival of mice with anthrax. Mice were infected with the bacteria B. anthracis. One group of 15 then began receiving a drug-free buffer solution 3 hours later. Another 15 were treated with Epimerox beginning 3 hours after infection. A third group of 15was treated with Epimerox beginning 24 hours after infection.
How long did it take for all the mice that received the drug-free buffer alone to die? What function did this group play in the experiment?
To determine: The days taken for all the mice to receive the drug-free buffer alone and die.
Introduction: Scientists developed an investigational broad spectrum of an antibiotic compound called Epimerox that inhibits or blocks the activity of an enzyme called epimerase. Epimerase is an enzyme found in Bacillus anthracis that is required to synthesize a polysaccharide in their cell wall. It is also essential for bacterial growth and for receptor expression. Epimerase is used as a model to produce the drug Epimerox. The bacteriophage-lysin enzyme has the capability to specifically bind with epimerase of bacteria and cause cell lysis. Bacillus could not develop a resistant mechanism to prevent the viruses from lysing their host cell wall. This was the idea behind to produce an antibiotic epimerase that could be effective against Bacillus anthracis.
Explanation of Solution
In the given case study, scientists had conducted certain experiments to determine the action of the Epimerox drug. The experimental groups of mice were infected with the bacteria Bacillus anthracis. The mice were grouped into 15 member groups. The first set of mice began to receive drug-free buffer after three hours of infection. At the same time, another set was treated with Epimerox antibiotics. The third set of mice was treated with Epimerox after 24 hours of infection. They observed the survival rate of mice of different groups, and the results were plotted in a graph (Refer Fig 20.2) showing the time (days) of survival versus percentage of survival. Refer Fig 20.2, “Effect of Epimerox on the survival of mice with anthrax”, in the textbook. The graph shows that the group of mice that were injected with drug-free buffer solution died within five days of infection.
The group of mice that were injected with drug-free buffer solution died within five days of infection.
To determine: The role of drug-free buffer in the given experiment.
Introduction: Epimerox inhibits or blocks the activity of an enzyme called epimerase. Epimerase is an enzyme found in Bacillus anthracis that is required to synthesize a polysaccharide in their cell wall. It is also essential for bacterial growth and for receptor expression. Epimerase is used as a model to produce the drug Epimerox.
Explanation of Solution
A solution that will resist the pH change by the addition of either acid or base is called buffer. The buffers are important to maintain the pH of a solution. In the given experiment, drug-free buffer serves as a control group to check the efficiency of the drug Epimerox against the Bacillus anthracis in other groups.
The drug-free buffer served as the control group.
Want to see more full solutions like this?
Chapter 20 Solutions
Biology: The Unity and Diversity of Life (Looseleaf)
Additional Science Textbook Solutions
Genetic Analysis: An Integrated Approach (3rd Edition)
Biological Science
Essentials of Human Anatomy & Physiology (11th Edition)
Microbiology with Diseases by Body System (4th Edition)
Anatomy & Physiology
- Match each antibacterial drug with its primary target. Chloramphenico✓ Choose... Nucleic acid synthesis Fluoroquinolone Cell membrane Cell wall Tetracycline Metabolic pathway Translation Rifampin Aminoglycosides Choose... Macrolide Choose... Penicillin Choose... Sulfonamides Choose... Cephalosporin Choose... Vancomycin Choose... Polymyxin Choose... → ( 4 ( ( ( (arrow_forwardA patient is asked to participate in a trial using a bacteriophage to treat a Streptococcus infection. The patient is worried that she will end up with a viral infection rather than a Streptococcal infection. How would you address her concerns? – discuss the specificity of viral infections. How do they infect host cells, is that a random process?arrow_forwardThe ribosome is the target for many important antibiotics. These drugs must discriminate between bacterial and eukaryotic ribosomes to achieve drug specificity and toxicity. For the two common antibiotics below, what is their mechanism of action and why are they more toxic to bacteria than eukaryotes? a) Tetracycline b) Erythromycinarrow_forward
- do not copy from cheggarrow_forwardIn a petri dish with solidified agar with escherichia coli, enterobacter aerogenes and staphylococcus aureus, you streak a loopfull of lytic T4-phage in a single line onto the center of the the dish, how do you know if bacteriophage infected the bacteria. why didn't the bacteriophage infect all 3 bacteria?arrow_forwardYou are designing a phage therapy for a cystic fibrosis patient with an multi-antibiotic resistant Mycobacterium infection. The Mycobacterium infection is preventing the patient from taking immunosuppressant drugs that are needed for a successful lung transplant. The idea is that introducing the right phage to the patient will kill the Mycobacterium cells and allow the patient to go on immunosuppressant drugs that will ensure the new lung is not rejected by the body. You need to find a phage that infects the Mycobacterium you isolated from the patient. Which TWO options have the highest chance of success? A. Screening a colleague's library of known Mycobacterium phages for phage that infect the patient's Mycobacterium isolate b. Choosing likely candidates from analysis of phage 16S rRNA phylogeny in the tree of life C. Isolating new phage from soil using a plaque assay with the Mycobacterium isolate D. Obtaining a very well-studied phage, such as T4 bacteriophage, that…arrow_forward
- You are designing a phage therapy for a cystic fibrosis patient with an multi-antibiotic resistant Mycobacterium infection. The Mycobacterium infection is preventing the patient from taking immunosuppressant drugs that are needed for a successful lung transplant. The idea is that introducing the right phage to the patient will kill the Mycobacterium cells and allow the patient to go on immunosuppressant drugs that will ensure the new lung is not rejected by the body. You finally find a phage that you think will work because it attaches to and injects its genome into the patient's Mycobacterium isolate. Next, you need to be sure of what characteristics of the phage infection cycle? Pick all that are true A. That the phage delivers new antibiotic resistance genes to Mycobacterium via transduction B. That the correct proteins are expressed during the phages metabolism C. That the infection is lytic D.That lysogeny is the primary infection pathwayarrow_forwardYou are designing a phage therapy for a cystic fibrosis patient with an multi-antibiotic resistant Mycobacterium infection. The Mycobacterium infection is preventing the patient from taking immunosuppressant drugs that are needed for a successful lung transplant. The idea is that introducing the right phage to the patient will kill the Mycobacterium cells and allow the patient to go on immunosuppressant drugs that will ensure the new lung is not rejected by the body. You need to find a phage that infects the Mycobacterium you isolated from the patient. Which TWO options have the highest chance of success? Group of answer choices 1.Isolating new phage from soil using a plaque assay with the Mycobacterium isolate 2.Choosing likely candidates from analysis of phage 16S rRNA phylogeny in the tree of life 3.Obtaining a very well-studied phage, such as T4 bacteriophage, that specifically targets E. coli 4.Screening a colleague's library of known Mycobacterium phages for phage that…arrow_forwardYou are studying your favorite (hypothetical) bacteriophage named M277. It infects E. coli and stays dormant within the bacterial cell. How does a phage become dormant within a cell? Generally, describe the steps of infection by phage in this scenarioarrow_forward
- Some retroviruses that have a wide host range have been developed for use in treatment of diseases or syndromes. These viruses do not result in a productive infection because they lack critical genes for viral replication, but they do carry DNA sequences that allow them to be packaged into infectious particles. Once in the host cell the viral DNA is released and integrates into the cell's genome. The advantage to this strategy is that the delivery of the DNA is very efficient. What is one possible problem of using a virus that can integrate into the human nuclear genome? Multiple Choice The virus carries genes that will interfere with host cell activities. The viral DNA sequences could still cause a disease. Since the viral DNA sequences no longer contain essential genes for viral replication the host cell may not be able to replicate either. The integration could disrupt an essential gene or genes.arrow_forwardSome mutations that occur in bacteria can cause the loss of phage receptors, and these bacteria become phage resistant. In order for a phage to infect the host bacterium, it is preferred that the cell wall is newly synthesized.why ?arrow_forwardPut the following stages of a lytic replication cycle in order, from earliest to latest stages: I. Synthesis, II. Assembly. II. Attachment, IV. Release, V. Entry O 1) III, II, V, I, IV 2) I, II, III, V, IV O 3) v, III, II, IV, I O4) 1, III, V, II, Iv O 5) III, V, I, II, IVarrow_forward
- Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage LearningBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStax